Suppr超能文献

挥发性麻醉与全静脉麻醉对心脏手术患者术后肺部并发症的影响:一项随机临床试验

Effect of Volatile Anesthesia Versus Total Intravenous Anesthesia on Postoperative Pulmonary Complications in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial.

作者信息

He Lei-Lei, Li Xue-Fei, Jiang Jia-Li, Yu Hong, Dai Shun-Hui, Jing Wei-Wei, Yu Hai

机构信息

Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China; Department of Anesthesiology, Sichuan Jinxin Women and Children's Hospital, Chengdu, China.

Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.

出版信息

J Cardiothorac Vasc Anesth. 2022 Oct;36(10):3758-3765. doi: 10.1053/j.jvca.2022.06.014. Epub 2022 Jun 19.

Abstract

OBJECTIVES

The purpose of this study was to evaluate the effect of volatile anesthesia and propofol-based total intravenous anesthesia (TIVA) on postoperative pulmonary complications (PPCs) among patients undergoing cardiac surgery.

DESIGN

Parallel-group, randomized controlled trial.

SETTING

Single-center tertiary care hospital.

PARTICIPANTS

Five hundred twenty-four patients undergoing cardiac surgery with cardiopulmonary bypass.

INTERVENTIONS

The patients were assigned randomly (1:1) to receive anesthesia maintenance with a volatile anesthetic (sevoflurane or desflurane) or propofol-based TIVA.

MEASUREMENTS AND MAIN RESULTS

The primary outcome was a composite of postoperative pulmonary complications within the first 7 postoperative days. The PPCs occurred in 118 of 262 patients (45.0%) in the volatile anesthesia group compared with 105 of 262 patients (40.1%) in the propofol-based intravenous anesthesia group (relative risk: 1.17 [95% CI 0.96-1.42], p = 0.123). There were no significant differences in the severity of PPCs within 7 days postoperatively, the occurrence and severity grade of PPCs within 30 days, the incidence of hypoxia, and 30-day mortality.

CONCLUSIONS

In adult patients undergoing cardiac surgery with cardiopulmonary bypass, general anesthesia with a volatile anesthetic compared with propofol-based TIVA had not reduced pulmonary complications within the first 7 days after surgery.

摘要

目的

本研究旨在评估挥发性麻醉和丙泊酚全静脉麻醉(TIVA)对心脏手术患者术后肺部并发症(PPCs)的影响。

设计

平行组随机对照试验。

地点

单中心三级护理医院。

参与者

524例接受体外循环心脏手术的患者。

干预措施

患者被随机(1:1)分配接受挥发性麻醉剂(七氟醚或地氟醚)或丙泊酚TIVA进行麻醉维持。

测量指标和主要结果

主要结局是术后第1个7天内术后肺部并发症的综合情况。挥发性麻醉组262例患者中有118例(45.0%)发生PPCs,而丙泊酚静脉麻醉组262例患者中有105例(40.1%)发生PPCs(相对风险:1.17 [95% CI 0.96 - 1.42],p = 0.123)。术后7天内PPCs的严重程度、30天内PPCs的发生情况和严重程度分级、缺氧发生率以及30天死亡率均无显著差异。

结论

在接受体外循环心脏手术的成年患者中,与丙泊酚TIVA相比,挥发性麻醉剂全身麻醉并未降低术后第1个7天内的肺部并发症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验